Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Tubercidin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 2055 Radiotherapy 1971 Cisplatin 1837 Carboplatin 1551 Gemcitabine 1443 Paclitaxel 1315 Bevacizumab 1306 pembrolizumab 1231 Docetaxel 1224 Oxaliplatin 1172 Capecitabine 1164 Fluorouracil 1078 Dexamethasone 975 Magnetic Resonance Spectroscopy 952 Nivolumab 932 Rituximab 923 Drug Therapy 899 Surveys and Questionnaires 891 Doxorubicin 844 Etoposide 839 Radiosurgery 808 Blood Specimen Collection 806 Irinotecan 782 Cytarabine 739 fludarabine 710 Leucovorin 679 Surgical Procedures, Operative 632 Lenalidomide 616 Biopsy 582 fludarabine phosphate 565

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05991388 2026-02-20

Glo-BNHL

University of Birmingham

Phase 2/3 Recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡